Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey.
Kirwan
C C
CC
Education and Research Building, Wythenshawe Hospital, Manchester M23 9LT.
Nath
E
E
Byrne
G J
GJ
McCollum
C N
CN
D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use; D001458:Bandages; D019538:Health Care Surveys; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011364:Professional Practice; D011795:Surveys and Questionnaires; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D000970:Antineoplastic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin